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Abstract  
 
Purpose – To establish and evaluate a psychotropic medication education group for men with 
intellectual disability on a secure psychiatric ward. 
 
Design / method / approach – A multidisciplinary team was convened to oversee the project. 
A curriculum was developed that covered major classes of psychotropic drugs as well as 
broader themes related to taking medication and general wellbeing. Each group session 
incorporated a range of teaching methods supported by accessible materials. Evaluation was 
by qualitative and quantitative methods.  
 
Findings – There was interest and enthusiasm for the group. Participant feedback was 
generally positive and most of those who completed the group reported achieving their 
personal learning goals. There was no significant difference in results of a medication 
knowledge test at baseline and at the end of the course. Feedback from group members and 
reflections of the course facilitators are discussed.    
 
Limitations – The results of this small-scale study may not be applicable to other groups or 
settings. Evaluation measures seemed unable to capture some elements of the group 
processes and outcomes. 
 
Practical implications – Establishing and running a psychoeducational group on a low-secure 
ward for men with intellectual disabilities is possible and potentially valuable. Learning from 
this project will be useful for others considering group-based interventions for people with 
intellectual disability.  
 
 Originality – This paper adds to the limited literature describing interventions to improve 
medication knowledge in people with intellectual disability. 
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Background 
 
There is ongoing controversy over the use of psychotropic medications for people with 
intellectual disability. Recent epidemiological studies utilising routinely-collected data from 
large primary care databases have highlighted notable discrepancies between the number of 
people with intellectual disability who are prescribed psychotropic medication and the 
number with a recorded mental illness for which it is licensed (Sheehan et al., 2015, Public 
Health England, 2015). In many cases, it seems that psychotropic medication is used to 
manage challenging behaviour; this is not necessarily inappropriate, but the evidence to 
support psychotropic drug use for challenging behaviour is lacking and many fear that a 
reliance on psychotropic medication detracts from the delivery of psychosocial interventions 
that might more effectively target the underlying cause of the behaviour and are necessary 
to improve quality of life. 
 
In England there is now a national initiative to reduce psychotropic medication prescribing for 
people with intellectual disability. The majority of attention has focused on antipsychotic 
medications, as the class of psychotropic that has historically been associated with greatest 
degree of prescribing and arguably has the most significant side-effect profile. However, the 
reduction or withdrawal of antipsychotic medication used for challenging behaviour risks 
harms as well as having potential benefits. A recent systematic review concluded that 
decisions to reduce antipsychotic medication used for challenging behaviour should be made 
on an individual basis and highlighted that setting and support factors must be optimised if 
attempts to withdraw antipsychotics used for challenging behaviour are to be successful 
(Sheehan and Hassiotis, 2016). Indeed, the NICE guidelines on management of challenging 
behaviour and prescribing guidance issued by the Royal College of Psychiatrists both contain 
a place for antipsychotic prescribing in challenging behaviour and the absence of mental 
illness, if supplemented by frequent medication review and the provision of additional multi-
disciplinary interventions (National Institute for Health and Care Excellence 2015, Royal 
College of Psychiatrists, 2016).  
  
This renewed focus on psychotropic medication use in people with intellectual disability has 
prompted reflection within clinical teams and motivated attempts to ensure that 
psychotropic medication is used in the most appropriate way. In this paper we describe a 
practice initiative aimed at improving knowledge and understanding of psychotropic 
medication in adult men with intellectual disability who are detained in a low secure 
psychiatric setting. 
 
Introduction 
 
People with intellectual disability should be informed about their treatment but often have 
poor knowledge and understanding of prescribed medication (Hall and Deb, 2008, Arscott et 
al., 2000, Crossley and Withers, 2009, Heslop et al., 2005). If patients are to offer valid 
consent, they must have at least a basic understanding of the treatment (including likely 
benefits and potential harms) and its alternatives (General Medical Council, 2006). Even in 
those who lack capacity to consent, it is considered good practice to provide information up 
to their level of understanding and to facilitate engagement in treatment decisions as far as 
possible. Despite this, and the central role that psychotropic medication often has in 
management of people with intellectual disability and mental illness, few methods aimed at 
improving the knowledge of people with intellectual disability have about prescribed 
medication have been described and formally evaluated (Strydom and Hall, 2001, Aman et 
al., 2007, Ferguson and Murphy, 2014). The consequences of poor health literacy are likely to 
include reduced satisfaction and treatment compliance, as well as medication errors and 
safety incidents (such as receiving too much, or too little medication).  
 
 
Psychoeducational groups have been developed in inpatient intellectual disability services 
and have a limited, but growing, evidence base to support their effectiveness (Rose et al., 
2014, Crowley et al., 2008, Douds et al., 2014). There are several advantages to group 
interventions, leading some authors to suggest that they are an under-utilised treatment 
modality (Fletcher, 1993). Group interventions can act as a social support system and 
discussion within the group allows for vicarious learning. They can be an efficient use of 
 resources and staff time as they allow several people to receive an intervention 
concomitantly. Some people with intellectual disability might prefer learning in group 
settings, where they can involve themselves to a degree that feels comfortable, over 
individual sessions where they might feel more pressure to perform. However there are also 
drawbacks to group interventions including loss of privacy and potential exposure of personal 
experiences and feelings. People with social impairments or anxiety may find accessing 
groups difficult and it is possible that personality clashes or tensions between group members 
might hinder the progress of the group (Gravestock and McGauley, 1994, British Psychological 
Society, 2016).  
 
Psychotropic medication education groups are a relatively common feature of the therapy 
programme offered in secondary care services and have been reported in a number of 
settings serving different patient groups (Gavin and Frey, 2012, Farkas, 1990, Kuipers et al., 
1994, Kavanagh et al., 2003, Bastiaens, 1992, Eisenmann, 2012). Several studies that 
evaluated the group intervention have reported modest benefits in knowledge (Farkas, 1990, 
Kavanagh et al., 2003), self-reported attitudes (Neizo and Murphy, 1983), and psychotropic 
medication compliance (Robinson et al., 1986), although other studies have failed to 
demonstrate benefit (Kuipers et al., 1994, Gavin and Frey, 2012). Given the diversity in 
delivery of the interventions and of the groups targeted, the variation in evaluation measures, 
and the necessary differences in educating people with intellectual disability, it is difficult to 
generalise results from existing literature and extrapolate them to our circumstances.  
 
To our knowledge there are no published reports of a medication education group in a 
specialist in-patient unit for adults with intellectual disability. The work that is probably most 
relevant to the current project is that of Ferguson and Murphy, who assessed the effect of 
training on the ability of adults with intellectual disability living in the community to give 
consent to their medication; after three group training sessions participants demonstrated 
greater ability to give consent to their prescribed medication (Ferguson and Murphy, 2014).  
 
We describe a psychoeducational group intervention on a ward which provides care for 15 
adult men with mild-moderate intellectual disability and a range of complex mental health 
problems associated with offending or challenging behaviour. Many patients on the ward 
 have multiple diagnoses including mental illness, personality disorder, and autism spectrum 
conditions. The ward offers assessment and intensive treatment from a multi-disciplinary 
staff team with a focus on recovery and risk-reduction. All patients are detained under civil or 
forensic Sections of the Mental Health Act (1983) and the majority are prescribed 
psychotropic medication.  
 
Our aim was to empower patients as partners in their care by increasing knowledge and 
understanding about psychotropic medication. We determined to achieve this by establishing 
a ward-based psychotropic medication education group that would provide a safe and 
supportive environment for patients to learn, discuss, and exchange information related to 
medication and mental wellbeing and recovery more generally.  
 
Method 
 
Course development 
 
A multi-disciplinary project team consisting of clinicians with experience working with people 
with intellectual disability was convened to oversee the project. A curriculum was devised 
that would cover all important psychotropic medication groups, as well as broader themes 
around medication use such as capacity and consent (table 1). For each class of medication 
we discussed indications, how they could help, possible side-effects along with how to 
manage these, monitoring requirements, and where to seek further information (Howland, 
2009). The group ran weekly for eight sessions. 
 
[Figure 1 near here] 
 
Figure 1 Course curriculum  
 
Most sessions were configured as semi-structured discussions led by the course primary 
facilitators (SG and RS). We endeavoured to create an informal atmosphere that allowed 
flexibility to respond to participant needs whilst maintaining overall group direction and 
ensuring fundamental material was covered. We were mindful of the difficulties that 
 participants might have with didactic and ‘classroom style’ teaching and incorporated a range 
of learning methods to maintain interest (Primeau and Frith, 2014). Sessions were interactive 
and participants were encouraged to share their own experiences, where they felt 
comfortable to do so.  
 
Additional materials were provided to supplement the discussion and as a resource that 
participants could refer to between sessions. These included the group contract and rules, 
personal copies of individual’s own drug charts, accessible information leaflets, and course 
worksheets, which participants kept in individual folders. Where suitable freely-available 
resources were available these were used and in other cases new materials were developed.   
 
Homework was assigned after three sessions. Tasks included making a list of the psychotropic 
medication prescribed and obtaining a leaflet for one of the medications. In week 6 
participants were asked to choose a topic of particular interest that could be delivered as a 
five-minute presentation to the rest of the group (figure 2).  
 
Positive reinforcement was used to motivate participants. A small prize was given for the best 
presentation and certificates were awarded at the end of the course.  
 
[Figure 2 near here] 
 
Figure 2 Topics chosen for microteachings 
 
Recruitment 
 
The group was advertised at the ward community meeting for several weeks prior to starting. 
Prospective participants were approached individually and the purpose of the group was 
explained in more detail. Attendance was voluntary and a contract was signed between the 
course lead and the participant.  
 
 We allowed patients who had not signed up to the group to attend a one or two sessions with 
the intention that these would act as an introduction and facilitate full participation in the 
next round of the group.  
 
Evaluation measures 
 
A range of outcomes were of interest in this study and evaluated using different means.  
 
Participants were asked for their positive and negative experiences of the group in verbal 
feedback sessions half way through (week 4) and at the end of the course (week 8). 
 
Facilitators spent time in a ‘debrief’ following each group session and reflected on what had 
worked well and any difficulties encountered. Records were kept and discussed with the 
project team.   
 
The effectiveness of the group in improving participant knowledge and confidence with 
prescribed medication was assessed by self-report and also by a test of medication 
knowledge. Participants were asked to rate their agreement with the following questions on 
a 5 point Likert scale (from “strongly disagree” to “strongly agree”): 
 
- I know enough about my medication (self-rated knowledge) 
- I am able to ask staff about my medication (self-rated skills) 
- I think medication is an important part of my treatment (attitude) 
 
Group members were supported to develop 2 or 3 personal learning objectives. The degree 
to which participants felt they had achieved these by the end of the course was tested using 
the same Likert scoring system described above. 
 
A test of medication knowledge was developed consisting of 20 statements that participants 
were asked to rate as ‘true’ or ‘false’. True and false statements were randomly distributed 
and the content of the quiz was covered in the course curriculum. Participants completed the 
same quiz at the beginning and end of the course.  
  
Results 
 
Recruitment and participants 
 
Six patients were recruited to the group (mean age 31 years, standard deviation 13.3). 
Participants had a range of psychiatric diagnoses and were at various stages in their recovery 
journey, although none were acutely mentally unwell at the time that the group was run. All 
were prescribed regular psychotropic medication for mental illness. Most participants 
attended all eight group sessions (median 8; range 6-8). The group ran on the ward on a 
Thursday morning between November 2016 and January 2017.  
 
Qualitative feedback 
 
Overall responses from participants about the acceptability of the group were positive and 
most of those who attended indicated that they found the group interesting and useful. A 
number of participants made suggestions for improvements to the group (figure 3). 
 
[Figure 3 near here] 
 
Figure 3 Participant feedback on the psychotropic medication education group 
 
Quantitative results 
 
Participants rated their knowledge of and comfort with medication highly at baseline; all 
participants reported they “strongly agree” with the statements “I know enough about my 
medication” and “I am able to ask staff about my medication,” and five out of the six strongly 
agreed with the statement “Medication is an important part of my treatment”. There were 
few differences by the end of the group in the self-report measures.   
 
 Five out of the six participants “strongly agreed” that they had met their personal objectives 
by attending the group, with the remaining participant indicating that he was “not sure” if 
they had been met.  
 
The psychotropic medication knowledge test was completed by all participants. Mean 
baseline score was 13.7 (standard deviation 1.862) and mean score at the end of the group 
was 13.3 (standard deviation 2.066). A paired Student’s t-test confirmed no statistically 
significant difference between pre- and post-group scores (t=0.250; p=0.813) (figure 4).  
 
[Figure 4 near here] 
 
Figure 4 Scatter plot showing pre- and post-group scores on the medication knowledge quiz 
(n=6).  
 
Discussion 
 
Methods for evaluating psychoeducational groups are not well described (Brown, 2005). In 
this paper we focused on several aspects of feasibility, that is; practical considerations of how 
to design and implement the intervention; the testing of measurement tools; and estimating 
parameters related to demand, acceptability and potential outcomes (Bowen et al., 2009).  
 
Demand We were pleasantly surprised to have experienced no difficulty in recruiting several 
ward patients to the group. Participants showed willingness to learn more about their 
medication and asked pertinent questions. There were a small number of patients on the 
ward who were too mentally unstable to participate and who were not recruited to the group.  
 
Acceptability We found that the medication education group was acceptable to participants. 
No participants dropped out of the group and, indeed, most attended all sessions. Participants 
reported both during formal feedback and informally that they had enjoyed the group. There 
were some useful suggestions for improvement which will be considered in future iterations 
of the group. One participant asked for sessions to be shortened to 30 minutes, and another 
requested refreshments be provided. Some participants felt annoyed with the small number 
 of people who were not members of the group but who attended one or two sessions to get 
a ‘taster’ of the group; these people tended to be less well and were perceived as disruptive.  
 
Practicality We anticipated some challenges in the practical aspects of running a new group 
on the ward. The group ran at 10am so as not to conflict with planned patient leave and other 
activities but a number of participants found it difficult to get ready for this time and the 
group often started a few minutes late.  
 
Running the group required no specific funding but did draw on the time and resources of 
several members of the team.  
 
Integration A key question in this evaluation was how the medication group would fit with 
the demands and constraints already placed on the ward staff, patients, and the activity and 
therapy timetable. We identified a morning session during which a suitable room was 
available and when there were few other scheduled activities, however there were inevitably 
some clashes and a small number potential participants that were not able to attend.  
 
Limited efficacy testing We did not demonstrate improvements in medication knowledge or 
beliefs about medication in the qualitative evaluation. This contrasts with the observations of 
the facilitators and the qualitative feedback received that suggested the group had positively 
impacted medication knowledge, and may be due to unsuitable instruments being used to 
measure outcomes (see limitations, below).  
 
Attending the group is also likely to have contributed to benefits in other, more nebulous 
domains that are difficult to quantify, such as improved therapeutic relationships and patient 
satisfaction.   
 
We know from evaluation of medication education groups in other populations that they can 
be an effective way of imparting knowledge, and can lead to tangible improvements in patient 
outcomes (Farkas, 1990, Kavanagh et al., 2003, Neizo and Murphy, 1983, Robinson et al., 
1986). However, as is common in many complex interventions, extracting the elements that 
 are essential for success is not straightforward and the current literature in this field is not 
sufficient to inform the design of the group.   
 
Running an educational group for people with intellectual disability adds an additional layer 
of complexity to the intervention, as limitations in cognitive ability can impact learning and 
differing strengths and needs amongst group members (for example, in literacy) is likely to be 
significant. Further experience of running the group and the introduction of creative and 
novel techniques will hopefully reveal the most effective methods of teaching and learning in 
this group. Giving people information only on the medications they are taking might be a 
more realistic way of improving necessary knowledge while avoiding information overload 
(Farkas, 1990).  
 
It is also possible that we did not observe an improvement in medication knowledge following 
the group as the cohort who attended were already interested in medication and had 
reasonably good baseline knowledge. Although the quiz results do not appear to support this, 
it is possible that our intervention was aimed at a level that was too elementary.  
 
 
Facilitator reflections 
 
A number of key themes emerged through discussions and debrief sessions with the project 
team. 
 
It was found to be vital to involve the wider multi-disciplinary team if a new group is to 
become fully embedded in an environment where there are competing demands for 
resources and attention. Ward staff helped in developing the group and supporting 
participants, both within and outside the group and we noticed that the group ran more 
smoothly when those with additional needs were supported by extra staff members joining 
the group. Group work might raise several issues that participants wish to discuss with staff 
outside group sessions, and staff can help to reiterate important messages at other times, for 
example, when administering medication or opportunistically. We found that participants did 
 not often do the homework that was set and we suggest in future groups that this supported 
by the ward team. 
 
The time commitment involved in developing materials, recruiting participants, running and 
evaluating the group was significant and probably greater than initially expected. Even 
seemingly simple practical issues require organisation and sometimes negotiation; advance 
planning and contingency arrangements are necessary.  
 
The primary facilitators (RS and SG) were both psychiatrists who worked on the ward and the 
potential for this to influence group dynamics and motivation to join the group was 
considered. Our impression was that participants were open and honest in discussing their 
medication and experiences, including voicing negative attitudes where held, and the 
presence of the medical team did not inhibit frank discussion or encourage acquiescence. 
Nonetheless, we must be mindful that the group was not an entirely neutral space and the 
other roles of the facilitators could present a distraction.   
 
We learned that facilitating a group requires particular skills that might not routinely be 
taught to healthcare professionals. Running the group was challenging but rewarding; 
sessions were enjoyable and resulted in an understanding of medication issues and patient 
perspectives that might not otherwise have been obtained.  
 
Enforcing boundaries and rules was sometimes difficult, particularly in the initial sessions 
when roles and responsibilities were being established. Over time a shared understanding did 
develop but the group always relied on a relatively high level of guidance and direction from 
the facilitators.  
 
Participants were known to each other prior to attending the group. This could have been a 
facilitator or a hindrance to the work of the group but our experience was that any pre-
existing interpersonal difficulties did not have a significant impact in the group sessions and 
few overt tensions between members were witnessed.  
 
 Participants attending this group did so voluntarily and tended to be relatively highly 
motivated. Other strategies (such as individual psychoeducation) are likely to be needed to 
deliver medication education to those patients who are less engaged or unable to participate 
in group learning. 
 
In this feasibility study it was expected that the group would develop naturally over time in 
response to feedback and facilitator reflections. We found it helpful to be open to feedback 
and flexible in how the group was delivered. Using a range of materials was helpful but we 
did also wonder whether additional methods for participant engagement could be employed, 
such as role plays/simulation, audio-visual materials, and creating artwork. 
 
Limitations 
 
This study reports the results of a small-scale intervention on a single-sex specialist ward and 
the findings might not be applicable to other settings or groups. However, we believe there 
are certain learning points which will be relevant to those establishing other 
psychoeducational groups for people with intellectual disability in in-patient and possibly also 
community settings (figure 5).   
 
Although efficacy testing was not a primary aim of this work, we failed to demonstrate any 
improvement in knowledge or beliefs about medication in the participants who attended the 
group. The group was too small to form any subgroups (either by IQ level or by diagnosis) that 
might be used to determine people for whom it is most effective.  
 
 
Our outcome measures appear not to have been sensitive enough to capture the learning and 
group processes that the qualitative feedback suggested had occurred. Participants seemed 
to over-estimate their knowledge and skills at baseline which made demonstrating 
improvement impossible. It is possible that the Likert scale questions encouraged 
acquiescence in the way that they were phrased. Similarly, the ‘true/false’ test of medication 
knowledge, although written with care, might not have been the best method to use in a 
group of intellectually disabled persons who may be quite suggestible.  
  
When planning the group we looked for a validated and objective measure of medication 
knowledge for people with intellectual disability but found that none existed; we therefore 
created our own quiz, run in a ‘true or false’ format, that covered the content of the group. 
As other authors have highlighted, this style of quiz is likely to result in a 50% score even if 
respondents guess the answer to every question, leading to inflated pre-group assessment 
and limiting the scope for improvement over time (Burns et al., 2011).  
 
 
To build on this work, further investigation focusing on outcomes is necessary, possibly by 
including proxy measures of patient medication knowledge. It is also important to establish 
whether improvements in medication knowledge translate to changes in behaviour or other 
important outcomes such as adherence and satisfaction, and if knowledge gained in a group 
is retained in the longer-term (British Psychological Society, 2016).  
 
[Figure 5 near here] 
 
Figure 5 – Learning points for running education groups for people with intellectual 
disability 
 
Conclusion 
 
People with intellectual disability should have information about their treatment and the 
medication they take. Our work shows that it is possible to run a psychoeducational group for 
people with intellectual disability and complex mental health needs in a low secure inpatient 
setting. Recognising the limitations of this feasibility study, the results of qualitative 
evaluation are encouraging; it seems that the group was valued and has the potential to 
deliver benefits. Further work is needed to establish outcome measures that can fully capture 
the group processes and outcomes in different domains. A number of practical considerations 
have been identified that will inform future iterations of the medication group and can be 
used by others to guide the development of psychoeducational groups in this population.  
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